Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-23-000007

Options or other derivatives

  • Chief Executive Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
BUNKA CHRISTOPHER Chief Executive Officer 2023-10-26 Grant or award · Stock Options +30,000 131,001 D
Loading xslF345X05/primary_doc.xml…